Effects of clonidine premedication on hemodynamic changes during laparoscopic cholecystectomy-A randomized control study

M. M. Chandrashekaraiah, M. Upadya, S. P. Jayachandran, M. Wali

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: Laparoscopic cholecystectomy is the treatment of choice for cholelithiasis. The pneumoperitoneum used for laparoscopic procedures leads to significant impairment of cardiopulmonary function. Methods: This randomized double blind study started with institute ethics committee approval. Sixty ASA 1 and ASA 2 patients undergoing elective laparoscopic cholecystectomy with no cardiovascular co-morbidity were enrolled for the study and received either tab clonidine 150 mcg [group C-30] or placebo drug tab lorazepam 2mg [group L30] orally one hour before the induction. Heart rate, systolic blood pressure, diastolic pressure and mean arterial pressure were recorded. The data obtained was analyzed using student's-test, ANOVA and Chi-square test. Results: There is significant reduction of heart rate (16.6003), systolic pressure (22.433) and mean arterial pressure (14.8) (p<0.001) in study group. Conclusion: From our study we found that oral clonidine 150mcg can effectively counteract the cardiovascular changes induced by pneumoperitoneum.

Original languageEnglish
Pages (from-to)91-98
Number of pages8
JournalApplied Cardiopulmonary Pathophysiology
Volume15
Issue number3
Publication statusPublished - 01-12-2011

Fingerprint

Premedication
Laparoscopic Cholecystectomy
Clonidine
Hemodynamics
Blood Pressure
Pneumoperitoneum
L 30
Arterial Pressure
Heart Rate
Lorazepam
Ethics Committees
Cholelithiasis
Chi-Square Distribution
Double-Blind Method
Analysis of Variance
Placebos
Students
Morbidity
Pharmaceutical Preparations
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

@article{4e84e51655a2457697b0510ea953eeeb,
title = "Effects of clonidine premedication on hemodynamic changes during laparoscopic cholecystectomy-A randomized control study",
abstract = "Purpose: Laparoscopic cholecystectomy is the treatment of choice for cholelithiasis. The pneumoperitoneum used for laparoscopic procedures leads to significant impairment of cardiopulmonary function. Methods: This randomized double blind study started with institute ethics committee approval. Sixty ASA 1 and ASA 2 patients undergoing elective laparoscopic cholecystectomy with no cardiovascular co-morbidity were enrolled for the study and received either tab clonidine 150 mcg [group C-30] or placebo drug tab lorazepam 2mg [group L30] orally one hour before the induction. Heart rate, systolic blood pressure, diastolic pressure and mean arterial pressure were recorded. The data obtained was analyzed using student's-test, ANOVA and Chi-square test. Results: There is significant reduction of heart rate (16.6003), systolic pressure (22.433) and mean arterial pressure (14.8) (p<0.001) in study group. Conclusion: From our study we found that oral clonidine 150mcg can effectively counteract the cardiovascular changes induced by pneumoperitoneum.",
author = "Chandrashekaraiah, {M. M.} and M. Upadya and Jayachandran, {S. P.} and M. Wali",
year = "2011",
month = "12",
day = "1",
language = "English",
volume = "15",
pages = "91--98",
journal = "Applied Cardiopulmonary Pathophysiology",
issn = "0920-5268",
publisher = "Pabst Science Publishers",
number = "3",

}

Effects of clonidine premedication on hemodynamic changes during laparoscopic cholecystectomy-A randomized control study. / Chandrashekaraiah, M. M.; Upadya, M.; Jayachandran, S. P.; Wali, M.

In: Applied Cardiopulmonary Pathophysiology, Vol. 15, No. 3, 01.12.2011, p. 91-98.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of clonidine premedication on hemodynamic changes during laparoscopic cholecystectomy-A randomized control study

AU - Chandrashekaraiah, M. M.

AU - Upadya, M.

AU - Jayachandran, S. P.

AU - Wali, M.

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Purpose: Laparoscopic cholecystectomy is the treatment of choice for cholelithiasis. The pneumoperitoneum used for laparoscopic procedures leads to significant impairment of cardiopulmonary function. Methods: This randomized double blind study started with institute ethics committee approval. Sixty ASA 1 and ASA 2 patients undergoing elective laparoscopic cholecystectomy with no cardiovascular co-morbidity were enrolled for the study and received either tab clonidine 150 mcg [group C-30] or placebo drug tab lorazepam 2mg [group L30] orally one hour before the induction. Heart rate, systolic blood pressure, diastolic pressure and mean arterial pressure were recorded. The data obtained was analyzed using student's-test, ANOVA and Chi-square test. Results: There is significant reduction of heart rate (16.6003), systolic pressure (22.433) and mean arterial pressure (14.8) (p<0.001) in study group. Conclusion: From our study we found that oral clonidine 150mcg can effectively counteract the cardiovascular changes induced by pneumoperitoneum.

AB - Purpose: Laparoscopic cholecystectomy is the treatment of choice for cholelithiasis. The pneumoperitoneum used for laparoscopic procedures leads to significant impairment of cardiopulmonary function. Methods: This randomized double blind study started with institute ethics committee approval. Sixty ASA 1 and ASA 2 patients undergoing elective laparoscopic cholecystectomy with no cardiovascular co-morbidity were enrolled for the study and received either tab clonidine 150 mcg [group C-30] or placebo drug tab lorazepam 2mg [group L30] orally one hour before the induction. Heart rate, systolic blood pressure, diastolic pressure and mean arterial pressure were recorded. The data obtained was analyzed using student's-test, ANOVA and Chi-square test. Results: There is significant reduction of heart rate (16.6003), systolic pressure (22.433) and mean arterial pressure (14.8) (p<0.001) in study group. Conclusion: From our study we found that oral clonidine 150mcg can effectively counteract the cardiovascular changes induced by pneumoperitoneum.

UR - http://www.scopus.com/inward/record.url?scp=84856872437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856872437&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 91

EP - 98

JO - Applied Cardiopulmonary Pathophysiology

JF - Applied Cardiopulmonary Pathophysiology

SN - 0920-5268

IS - 3

ER -